4-(substituted cycloalkylmethyl) imidazole-2-thiones,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S300100, C548S316400, C548S325100, C514S385000, C514S386000

Reexamination Certificate

active

07419994

ABSTRACT:
Compounds of Formula 1where X is S and the variables have the meaning defined in the specification are specific or selective to alpha2Band/or alpha2Cadrenergic receptors in preference over alpha2Aadrenergic receptors, and as such have no or only minimal cardivascular and/or sedatory activity. These compounds of Formula 1 are useful as medicaments in mammals, including humans, for treatment of diseases and or alleviations of conditions which are responsive to treatment by agonists of alpha2Badrenergic receptors. Compounds of Formula 1 where X is O also have the advantageous property that they have no or only minimal cardivascular and/or sedatory activity and are useful for treating pain and other conditions with no or only minimal cardivascular and/or sedatory activity.

REFERENCES:
patent: 3996366 (1976-12-01), Baker et al.
patent: 4798834 (1989-01-01), Merritt et al.
patent: 5441970 (1995-08-01), Reitz et al.
patent: 5648373 (1997-07-01), Winkler et al.
patent: 5861420 (1999-01-01), Reitz et al.
patent: 5929103 (1999-07-01), Yoon et al.
patent: 5932742 (1999-08-01), Yoon et al.
patent: 6043373 (2000-03-01), Yoo et al.
patent: 6313172 (2001-11-01), Chow et al.
patent: 6534542 (2003-03-01), Chow et al.
patent: 6545182 (2003-04-01), Chow et al.
patent: 7091232 (2006-08-01), Chow et al.
patent: 7141597 (2006-11-01), Chow et al.
patent: 7276522 (2007-10-01), Heidelbaugh et al.
patent: 2002/0094998 (2002-07-01), Burke et al.
patent: 1 499 485 (1978-02-01), None
patent: WO 92/0073 (1992-01-01), None
patent: WO 99/28300 (1999-06-01), None
patent: WO 01/00586 (2001-01-01), None
patent: WO 02/36162 (2002-05-01), None
Messier et al, Pharmacol. Toxicol., 1995, p. 308-311, 76.
Conklin et al., Nature, 1993, p. 274-276, 363.
Dirig, et al., J. Neurosci. Methods, 1997, p. 183-191, 76.
Hargreaves, et al., Pain, 1988, p. 77-88, 32.
Kim et al., Pain, 1992, p. 355-363, 150.
Dixon et al., Ann. Rev. Pharmacol. Toxicol., 1980, p. 441-462, 20.
Cook et al., J. Org. Chem., 1980, 45, 1046.
Horne et al., Heterocycles, 1994, 39, 139.
Woods et al., J. Amer. Chem. Soc., 1949, 71, 2020.
Hua et al., J. Org. Chem. 1997, 62, 6888.
Jennesken et al., J. Org. Chem. 1986, 51, 2162.
Kim et al., Synthesis, 1993, 283.
Kowalski et al., J. Org. Chem., 1982, 47, 5088.
Huang et al., Synthetic Communications, 1998, 28, 1197.
Ciufolini et al., J. Amer. Chem. Soc., 1991, 113, 8016.
Mancuso, Synthesis, 1981, p. 165.
Corey et al., Tetrahedron Lett., 1989, 30, 6275.
Xavier et al., Organic Synthesis, 1996, 74, 50.
Molina et al., Tetrahedron, 1995, 51, 1265.
Lemke et al., J. Med. Chem., 1977, 20, 1351.
Berque et al., J. Org. Chem., 1999, 373.
Organ et al., J. Org. Chem., 1997, 62, 1523.
Sosa et al., J. Org. Chem., 2002, 4498-4500, 67.
Yoon et al., (1998): STN International CAPLUS data base, Columbus (Ohio), Accession No. 1998: 147327.
Jackman et al., (1949): STN International CAPLUS database, Columbus (Ohio), Accession No. 1949: 2664.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

4-(substituted cycloalkylmethyl) imidazole-2-thiones,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-(substituted cycloalkylmethyl) imidazole-2-thiones,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(substituted cycloalkylmethyl) imidazole-2-thiones,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3972874

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.